Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4581583
Max Phase: Preclinical
Molecular Formula: C21H25N5O3
Molecular Weight: 395.46
Molecule Type: Unknown
Associated Items:
ID: ALA4581583
Max Phase: Preclinical
Molecular Formula: C21H25N5O3
Molecular Weight: 395.46
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cccc2c1CC[C@H](N1CCn3c(nc4c3c(=O)n(C)c(=O)n4C)C1)C2
Standard InChI: InChI=1S/C21H25N5O3/c1-23-19-18(20(27)24(2)21(23)28)26-10-9-25(12-17(26)22-19)14-7-8-15-13(11-14)5-4-6-16(15)29-3/h4-6,14H,7-12H2,1-3H3/t14-/m0/s1
Standard InChI Key: DYAFWGMDXBEDQU-AWEZNQCLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 395.46 | Molecular Weight (Monoisotopic): 395.1957 | AlogP: 0.82 | #Rotatable Bonds: 2 |
Polar Surface Area: 74.29 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 6.51 | CX LogP: 1.70 | CX LogD: 1.64 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.64 | Np Likeness Score: -0.65 |
1. Brunschweiger A, Koch P, Schlenk M, Rafehi M, Radjainia H, Küppers P, Hinz S, Pineda F, Wiese M, Hockemeyer J, Heer J, Denonne F, Müller CE.. (2016) 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors., 24 (21): [PMID:27658798] [10.1016/j.bmc.2016.09.003] |
Source(1):